Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience
Titel:
Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience
Auteur:
Choucair, Khalil Page, Seth J. Mattar, Bassam I. Dakhil, Christopher S. Nabbout, Nassim H. Deutsch, Jeremy M. Truong, Quoc V. Truong, Phu V. Moore Jr., Dennis F. Cannon, Michael W. Kallail, K. James Moore, Joseph A. Dakhil, Shaker R. Diab, Radwan Kamran, Syed Reddy, Pavan S.